From: Predictors of the chest CT score in COVID-19 patients: a cross-sectional study
Variables | All patients N = 478 |
---|---|
Pulmonary involvement scores* | |
 RUL Total Score | 1.57 (1.75) |
 RML Total Score | 1.26 (1.71) |
 RLL Total Score | 1.91 (1.84) |
 LUL Total Score | 1.56 (1.72) |
 LLL Total Score | 1.79 (1.84) |
 Total pulmonary involvement Score | 8.11 (8.08) |
Frequency of lobe involvement | |
 RUL | 266 (55.5%) |
 RML | 225 (47%) |
 RLL | 304 (63.5%) |
 LUL | 274 (57.3%) |
 LLL | 287 (60%) |
Laterality of lung involvement | |
 Unilateral | 52 (10.8%) |
 Bilateral | 286 (59.8) |
Pattern of lesions | |
 GGO | 280 (58.5%) |
 Consolidation | 99 (20.7%) |
 Mixed GGO and consolidation | 78(16.3%) |
Dominant distribution of lesions | |
 Peripheral | 158 (33%) |
 Central | 6 (1.3%) |
 Diffuse | 153 (32%) |
 Peri broncho vascular | 161 (33.7%) |
Shape of lesions | |
 Round | 73 (15.2%) |
 Elongated | 82 (17.1%) |
 Wedged | 183 (38.2%) |
 Confluent | 226 (47.2%) |
Additional findings | |
 Crazy paving pattern | 87 (31%) |
 Reverse-halo | 14 (2.9%) |
 Interlobular septal thickening | 20 (4.1%) |
 Linear opacities combined | 81 (16.9%) |
 Air bronchogram sign | 114 (23.8%) |
 Tree in bud | 15 (3.1%) |
 Adjacent pleura thickening | 15 (3.1%) |
 Pleural effusion | 27 (5.6%) |
  Unilateral | 12 (2.5%) |
  Bilateral | 15 (3.1%) |
 Pericardial effusion | 10 (2%) |
 Lymphadenopathy | 7 (1.4%) |
 Pulmonary emphysema | 10 (2%) |